Goodwin Partner Michael McGrail, from Boston, practices in Technology among many other areas.

Michael McGrail

Partner
Spoken Languages
English German
Michael McGrail
Boston
+1 617 570 1137

A partner in Goodwin’s Technology group, Michael McGrail’s practice includes the representation of company and investor clients in a full range of corporate legal projects, including mergers and acquisitions, private financings, corporate partnerships, and technology licensing. He counsels companies and investors in many industries, with a particular focus on medical devices and life sciences. Michael is fluent in German, and a significant portion of his practice is devoted to international transactions.

Experience

M&A Transactions:

  • Represented Tillotts in its joint venture with TVM Capital Life Science*
  • Represented Baylis in its acquisition by Boston Scientific*
  • Represented BASF in its acquisition of Becker Underwood* 
  • Represented TYRX in its acquisition by Medtronic* 
  • Represented HyperBranch Medical Technology in its acquisition by Stryker*
  • Represented Image Stream Medical in its acquisition by Olympus* 
  • Represented Impact Instrumentation is its acquisition by ZOLL Medical*
  • Represented SuppreMol in its acquisition by Baxter*
  • Represented Carl Zeiss in a strategic collaboration with, and ultimate acquisition of, Oraya Therapeutics*
  • Represented Entellus Medical in its acquisition of CogENT Therapeutics assets* 
  • Represented Urban Decay in its acquisition by L’Oreal* 
  • Represented SVOX in its acquisition by Nuance*

Venture Financings:

  • Represented PartsTech in connection with its $35m Series C financing*
  • Represented General Catalyst in its Series B investment in Helsing*
  • Represented Casana Health in its $30m Series B Preferred Stock Financing* 
  • Represented argenx BV in its investment in OncoVerity*
  • Represented Podimetrics in its $45m Series C Preferred Stock Financing* 
  • Represented Luminopia in its $16m Series A Preferred Stock Financing*
  • Represented VideaHealth in its $20m Sereis A Preferred Stock Financing* 
  • Represented Probably Genetic in its $11m Series A Preferred Stock Financing*
  • Represented InGeneron in its $43m Series D Preferred Stock Financing* 
  • Represented Melodi Health in its $10m Series A Preferred Stock Financing*
  • Represented BASF in a $50m equity investment and collaboration with Sion Power* 
  • Represented Allianz in Lemonade’s $300m Series D Preferred Stock Financing* 
  • Represented Allianz in its $58m preferred stock investment in American Well*
 *Denotes experience prior to joining Goodwin

Professional Experience

Prior to joining Goodwin, Michael was a partner at Cooley.

Credentials

Education

JD2001

Boston College Law School

BA1993

Northeastern University

Admissions

Bars

  • Massachusetts